Temsirolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Clinical trial NCT01902160 · COMPLETED
Trial details
- NCT number
- NCT01902160
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2015-05-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.